Serotonin Signaling Pathway is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Serotonin (5-hydroxytryptamine or 5-HT) is a crucial monoamine neurotransmitter that regulates mood, sleep, appetite, cognition, memory, and numerous other physiological functions. Serotonin signaling is mediated by at least 14 receptor subtypes (5-HT1-5-HT7, plus additional subtypes), making it one of the most complex neurotransmitter systems. Dysregulation of serotonin signaling is strongly implicated in depression, anxiety, and other neuropsychiatric disorders.
| Enzyme | Function | Gene |
|---|---|---|
| Tryptophan hydroxylase (TPH) | Rate-limiting step | TPH1, TPH2 |
| Aromatic L-amino acid decarboxylase (AADC) | 5-HT synthesis | DDC |
| VMAT2 | Vesicular packaging | SLC18A2 |
| Monoamine oxidase A (MAO-A) | 5-HT degradation | MAOA |
| MAO-B | 5-HT degradation | MAOB |
| Receptor | Distribution | Function |
|---|---|---|
| 5-HT1A | Raphe nuclei, hippocampus | Autoreceptor, anxiety, depression |
| 5-HT1B | Basal ganglia, substantia nigra | Motor control, aggression |
| 5-HT1D | Cranial vessels | Migraine |
| 5-HT1E | Cortex, hippocampus | Cognitive functions |
| 5-HT1F | Peripheral tissues | Migraine |
| Receptor | Distribution | Function |
|---|---|---|
| 5-HT2A | Cortex, platelets | Psychosis, platelet aggregation |
| 5-HT2B | Gut, heart | Cardiovascular effects |
| 5-HT2C | Choroid plexus, hypothalamus | Appetite, mood |
| Receptor | Distribution | Function |
|---|---|---|
| 5-HT4 | Hippocampus, striatum | Learning, memory |
| 5-HT6 | Cortex, striatum | Cognition |
| 5-HT7 | Hypothalamus, hippocampus | Circadian rhythm, mood |
| Target | Drug Class | Examples |
|---|---|---|
| SERT | SSRIs | Fluoxetine, sertraline |
| SERT | SNRIs | Venlafaxine, duloxetine |
| 5-HT1A | Partial agonists | Buspirone |
| 5-HT1B/1D | Agonists | Sumatriptan |
| 5-HT2A | Antagonists | Risperidone |
| 5-HT2C | Antagonists | Lorcaserin |
| 5-HT3 | Antagonists | Ondansetron |
| 5-HT4 | Agonists | Prucalopride |
| 5-HT6 | Antagonists | Idalopirdine |
| 5-HT7 | Antagonists | Amisulpride |
The study of Serotonin Signaling Pathway has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
🔴 Low Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 8 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |
Overall Confidence: 29%